Zobrazeno 1 - 10
of 378
pro vyhledávání: '"Harvey, RD"'
Publikováno v:
American Journal of Men's Health, Vol 14 (2020)
Overweight and obese men were recruited to a 6-month, randomized controlled weight loss trial, which compared the Gutbusters weight loss program alone to the Gutbusters program with incentives for successful weight loss. The intervention was delivere
Externí odkaz:
https://doaj.org/article/29e96e58b63d443b99153966b6239e3b
Publikováno v:
American Journal of Men's Health, Vol 13 (2019)
Obese men are at an increased risk of chronic disease and are far less likely than women to attempt weight loss. There is a need to successfully recruit men to weight loss clinical trials. Overweight and obese men were recruited to a 6-month, randomi
Externí odkaz:
https://doaj.org/article/0fe05cff504b44e887bff219f051404b
Autor:
Harvey RD
Publikováno v:
Clinical Pharmacology: Advances and Applications, Vol 2014, Iss default, Pp 87-96 (2014)
R Donald HarveyPhase 1 Clinical Trials Section, Winship Cancer Institute of Emory University, Atlanta, GA, USAAbstract: Carfilzomib, a selective proteasome inhibitor approved in the USA in 2012, is a single agent for relapsed and refractory multiple
Externí odkaz:
https://doaj.org/article/e61e73945e8e499f9a1d996fbc7afd8c
HT61 is a quinoline-derived antimicrobial, which exhibits bactericidal potency against both multiplying and quiescent methicillin resistant and sensitive Staphylococcus aureus, and has been proposed as an adjunct for other antimicrobials to extend th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3186c6e0349ca7fc5f382437bcd35958
Autor:
Wu, B, Lewis, LD, Harvey, RD, Rasmussen, E, Gamelin, E, Sun, Y‐N, Friberg, G, Koyner, JL, Dowlati, A, Maitland, ML
Publikováno v:
Clinical Pharmacology & Therapeutics; Aug2017, Vol. 102 Issue 2, p313-320, 8p
Publikováno v:
Cancer Practice. Mar/Apr98, Vol. 6 Issue 2, p133-135. 3p.
Autor:
CL Lindley, RD Harvey rd
Publikováno v:
Cancer practice. 6(2)
Autor:
Harvey Rd rd
Publikováno v:
Pharmacotherapy. 25:71S-72S
Publikováno v:
American Journal of Health-System Pharmacy. 67:S2-S2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.